Attached files

file filename
8-K - 8-K - DENDREON CORPd855036d8k.htm

Exhibit 99.1

THE UNITED STATES BANKRUPTCY COURT

FOR THE DISTRICT OF DELAWARE

 

 

  x   

 

In re:

 

DENDREON CORPORATION, et al.,

 

Debtors.1

  :

:

:

:

:

:

:

:

  

 

        Chapter 11

 

        Case No. 14-12515 (PJW)

 

        Jointly Administered

 

  x   

NOTICE OF FILING OF DEBTORS’ MONTHLY OPERATING REPORT

FOR THE PERIOD OF DECEMBER 2014

PLEASE TAKE NOTICE that the above-captioned debtors and debtors in possession (collectively, the “Debtors”) have filed with the United States Bankruptcy Court for the District of Delaware the Debtors’ Monthly Operating Report for the Period of December 2014,

 

1  The Debtors and the last four digits of their respective taxpayer identification numbers are as follows: Dendreon Corporation (3193), Dendreon Holdings, LLC (8047), Dendreon Distribution, LLC (8598) and Dendreon Manufacturing, LLC (7123). The address of the Debtors’ corporate headquarters is 1301 2nd Avenue, Seattle, Washington 98101.


attached hereto as Exhibit A (the “Monthly Operating Report”).

Dated: Wilmington, Delaware

            January 20, 2015

 

SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP

 

/s/ Sarah E. Pierce

Anthony W. Clark (I.D. No. 2051)

Sarah E. Pierce (I.D. No. 4648)

One Rodney Square

P.O. Box 636

Wilmington, Delaware 19899-0636

Telephone: (302) 651-3000

Fax: (302) 651-3001

 

- and -

 

Kenneth S. Ziman

Raquelle L. Kaye

Four Times Square

New York, New York 10036-6522

Telephone: (212) 735-3000

Fax: (212) 735-2000

 

- and -

 

Felicia Gerber Perlman

155 N. Wacker Drive

Chicago, Illinois 60606-1720

Telephone: (312) 407-0700

Fax: (312) 407-0411

 

Counsel for Debtors and Debtors in Possession

 

2


EXHIBIT A

MONTHLY OPERATING REPORT


UNITED STATES BANKRUPTCY COURT

                     DISTRICT OF DELAWARE                     

 

In re     DENDREON CORPORATION, et. al                        Case No.    14-12515_(LSS)                       
   Reporting Period:     December 2014  
MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month.

Submit copy of report to any official committee appointed in the case.

 

    REQUIRED DOCUMENTS    Form No.   

Document

Attached

  

Explanation

Attached

  

  Affidavit/Supplement  

Attached

Schedule of Cash Receipts and Disbursements

   MOR-1    X          

Bank Reconciliation (or copies of debtor’s bank reconciliations)

   MOR-1a    X          

Schedule of Professional Fees Paid

   MOR-1b         X     

Copies of bank statements

             X     

Cash disbursements journals

             X     

Statement of Operations

   MOR-2    X          

Balance Sheet

   MOR-3    X          

Status of Postpetition Taxes

   MOR-4         X     

Copies of IRS Form 6123 or payment receipt

                   

Copies of tax returns filed during reporting period

                   

Summary of Unpaid Postpetition Debts

   MOR-5    X          

Listing of aged accounts payable

   MOR-5    X          

Accounts Receivable Reconciliation and Aging

   MOR-6    X          

Debtor Questionnaire

   MOR-7    X          

I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents

are true and correct to the best of my knowledge and belief.

 

 

    

 

Signature of Debtor      Date

 

 

    

 

 

Signature of Joint Debtor      Date

 

/s/ Gregory R. Cox

    

 

January 20, 2014

Signature of Authorized Individual*     

 

Gregory R. Cox

    

 

Interim Chief Financial Officer

Printed Name of Authorized Individual      Title of Authorized Individual

*Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor

is a partnership; a manager or member if debtor is a limited liability company.


 

 NOTES

 

Notes to the MOR:

This Monthly Operating Report (“MOR”) has been prepared solely for the purpose of complying with the monthly reporting requirements applicable in the Bankruptcy Case and is in a format acceptable to the U.S. Trustee. The financial information contained herein is limited in scope and covers a limited time period. Moreover, such information is preliminary and unaudited, and is not prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. Accordingly, this MOR should not be used for investment purposes.

The financial statements presented in MOR-2 and MOR-3 are prepared on a consolidated company basis for the Debtors and non-debtor affiliates.

 

Page 2 of 13


 

 1. SCHEDULE OF CASH RECEIPTS AND DISBURSEMENTS

 

($ 000s)

 

               
For the period 11/29/14 - 1/2/151                   Dendreon           Dendreon            Dendreon     Dendreon  
           Consolidated                          Corporation           Holdings            Distribution                 Manufacturing        
 

Beginning Cash Balance2

    $             100,952             $ 100,952       $                         -        $ -       $         -   
 

Total Cash Receipts

     32,446              796        -                 31,649        -   
 

Total Cash Disbursements3

     (17,683           (17,683     -         -        -   
 

Intercompany Transfer From / (To) Other Debtors

     -              31,649        -         (31,649     -   
 

Intercompany Transfer From / (To) Non-Debtors

 

    

 

-

 

  

 

         

 

-

 

  

 

   

 

-

 

  

 

    

 

-

 

  

 

   

 

-

 

  

 

  

 

 

         

 

 

   

 

 

    

 

 

   

 

 

 
 

Net Cash Flow

 

    $

 

14,762

 

  

 

         $

 

14,762

 

  

 

   $

 

-

 

  

 

    $

 

-

 

  

 

   $

 

-

 

  

 

  

 

 

         

 

 

   

 

 

    

 

 

   

 

 

 
 

Ending Cash Balance2

    $ 115,714             $ 115,714       $ -        $ -       $ -   

Notes:

 

1. 1/2/15 represents last day of Debtors’ December weekly cash forecast

2. Excludes restricted cash accounts

3. Cash Disbursements include payroll that was disbursed by Dendreon Corporation through its centralized cash management system for the benefit of subsidiary debtors. Accordingly, disbursement amounts (for the purposes of calculating US Trustee fees) are as follows:

 

   

Debtor

       Amounts              
 

Dendreon Corporation

     13,278      
 

Dendreon Holdings

     -          
 

Dendreon Distribution

     1,864      
 

Dendreon Manufacturing

     2,541      
    

 

 

   
      $ 17,683      

 

Page 3 of 13


 

 1a. BANK RECONCILIATION (OR COPIES OF DEBTORS’ BANK RECONCILIATIONS)

 

 

As of 12/31/14   
                               Restricted Cash Accounts  
Bank    U.S. Bank     

Morgan Stanley

Smith Barney

     U.S. Bank1           U.S. Bank      Wells Fargo  
Description            Operating Account              Investment Account              Payroll Account                   Escrow Account              LC Account  

Bank Balance

   $ 36,942,055        $ 79,569,680        $ 87,255           $ 214,380        $ 5,206,211    

(+) Deposits in Transit

                                          

(-) Outstanding Checks

     (519,884)                 (12,427)                      

Other

                                          
  

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

Book Balance

   $ 36,422,171        $ 79,569,680        $ 74,828           $ 214,380        $ 5,206,211    

Notes:

 

1. Account opened during postpetition period

 

Page 4 of 13


 

 1b. SCHEDULE OF PROFESSIONAL FEES PAID

 

For the period 12/1/14 - 12/31/14, no payments were made to retained professionals

 

Page 5 of 13


 

 1c. COPIES OF BANK STATEMENTS

 

The Debtors’ bank statements are voluminous and not included herein, but copies will be provided upon request

 

Page 6 of 13


 

 1d. CASH DISBURSEMENTS JOURNALS

 

The Debtors’ cash disbursement journals are voluminous and not included herein, but copies will be provided upon request

 

Page 7 of 13


 

 2. STATEMENT OF OPERATIONS

 

($ 000s)

 

For the period 12/1/14 - 12/31/14        Consolidated1                  Dendreon
    Corporation    
        Dendreon    
Holdings
    Dendreon
    Distribution    
    Dendreon
    Manufacturing    
 
 

Product Revenue, net

   $                 28,765            $                 28,765      $                         -      $                         -      $                         -   

Royalty and Other Revenue

     12              12        -        -        -   
  

 

 

         

 

 

   

 

 

   

 

 

   

 

 

 
 

Total Revenue

   $ 28,777            $ 28,777      $ -      $ -      $ -   
 

Operating Expenses:

                

Cost Of Product Revenue

     12,478              12,478        -        -        -   

Inventory Impairment / (Recovery)

     -              -        -        -        -   

Research and Development

     4,979              4,979        -        -        -   

Selling, General and Administrative

     10,339              10,339        -        -        -   

Less: Payroll Expense Included In Categories Above2

     (5,836           (5,836     -        -        -   

Payroll Expense2,3

     5,836              1,431        -        1,864        2,541   

Restructuring

     5,566              5,566        -        -        -   
  

 

 

         

 

 

   

 

 

   

 

 

   

 

 

 
 

Total Operating Expenses

   $ 33,362            $ 28,957      $ -      $ 1,864      $ 2,541   
  

 

 

         

 

 

   

 

 

   

 

 

   

 

 

 
 

Income / (Loss) from Operations

   $ (4,585         $ (180   $ -      $ (1,864   $ (2,541
 

Other Income / (Expense):

                

Interest Income

     39              39        -        -        -   

Interest Expense

     (413           (413     -        -        -   

Other Income / (Expense)

     (1           (1     -        -        -   
  

 

 

         

 

 

   

 

 

   

 

 

   

 

 

 
 

Net Income / (Loss)

   $ (4,960         $ (555   $ -      $ (1,864   $ (2,541

Notes:

 

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only. This modified presentation reflects cash basis payroll of the subsidiary entities, which is funded by Dendreon Corp.

2. The Debtors’ consolidated statement of operations reflects an allocation of payroll expenses among several operating expense categories (i.e., Cost of Product Revenue, R&D and SG&A). For the purpose of presenting payroll by entity without double-counting of such expenses, the cash basis payroll must be deducted before being included separately

3. Payroll Expense (noted above) includes payroll, payroll taxes and 401(k). These amounts are funded to ADP via the US Bank Operating account. For taxation purposes, each legal entity pays separate state employment taxes for the states in which it operates

 

Page 8 of 13


 

 3. BALANCE SHEET

 

($ 000s)

 

As of 12/31/14     
           Consolidated1      

 

Current Assets:

    

Cash and Cash Equivalents

     $ 101,480  

Short-Term Investments

       15,080  

Trade Accounts Receivable

       27,649  

Inventory

       61,617  

Prepaid Expenses and Other Current Assets

       25,149  
    

 

 

 

Total Current Assets

     $             230,975  

Property and Equipment, net

       102,410  

Long-Term Investments

       5,179  

Other Assets

       4,219  
    

 

 

 

Total Assets

     $ 342,783  

Current Liabilities2:

    

Accounts Payable

     $ 6,275  

Accrued Liabilities

       25,334  

Accrued Compensation

       18,978  

Restructuring Liability

       6,932  

Current Portion of Capital Lease Obligations

       2,395  

Current Portion of Facility Lease Obligations

       699  
    

 

 

 

Total Current Liabilities

     $ 60,614  

Long-Term Liabilities2:

    

Long-Term Accrued Liabilities

       5,794  

Capital Lease Obligations, Less Current Portion

       963  

Facility Lease Obligations, Less Current Portion

       9,362  
    

 

 

 

Total Long-Term Liabilities

     $ 16,120  

Liabilities Subject to Compromise2:

    

Accounts Payable

       5,284  

Convertible Senior Notes due 2016, Net of Discount

       583,533  

Other2

       TBD  
    

 

 

 

Total Liabilities Subject to Compromise

     $

 

588,817

 

 

 

    

 

 

 

Total Liabilities

     $ 665,551  

Stockholders’ Equity:

    

Common Stock

       155  

Additional Paid-In Capital

       2,004,520  

Accumulated Other Comprehensive Income

       (2 )

Accumulated Deficit

       (2,327,440 )
    

 

 

 

Total Stockholders’ Equity (Deficit)

     $

 

(322,768

 

)

 

    

 

 

 

Total Liabilities and Stockholders’ Equity

     $ 342,783  

 

Notes:

1. The Debtors maintain their accounting records and prepare financial statements on a consolidated basis only

 

2. The Debtors are currently working to determine the proper balance and reporting for Liabilities Subject to Compromise. Once determined, certain liabilities are likely to be reclassified from Current and Long-Term Liabilities to Liabilities Subject to Compromise

 

Page 9 of 13


 

 4. STATUS OF POSTPETITION TAXES

 

All postpetition taxes were current as of 12/31/14 and paid in the ordinary course by the Debtors

 

Page 10 of 13


 

 5. SUMMARY OF UNPAID POSTPETITION DEBTS

 

As of 12/31/14

 

          Days Outstanding
     Total    1 - 30    31 - 60    61 - 90    91 +

Postpetition Accounts Payable

     $     6,274,956        $         6,067,607        $         207,349        $                 -        $                 -  

 

Page 11 of 13


 

 6. ACCOUNTS RECEIVABLE RECONCILLIATION & AGEING

 

As of 12/31/14

 

         Days Outstanding
     Total   1 - 30    31 - 60    61 - 90    91 +

Gross Accounts Receivable

     $         29,711,026       $         30,754,944        $         (1,120,789)         $         110,406        $         (33,535)   

Accounts Receivable Offset - Chargebacks

       (2,062,111 )                   
    

 

 

                    

Net Accounts Receivable

     $ 27,648,915                     

 

Page 12 of 13


 

 7. DEBTOR QUESTIONNAIRE

 

 

                     Yes                                     No                 

1.  Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below

 

        X

 

2.  Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below

 

        X

 

3.  Have all postpetition tax returns been timely filed? If no, provide an explanation below

 

   X

 

    

4.  Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below

 

   X

 

    

5.  Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3

      X

 

Page 13 of 13


DENDREON CORP.

13-Week Cash Flow Forecast

(Dollars in Thousands)

 

    Actual     Projected     13-Week
Total
 
 

 

 

   
Week:   1     2     3     4     5     6     7     8     9     10     11     12     13    
Ending Date:   1/9/15     1/16/15     1/23/15     1/30/15     2/6/15     2/13/15     2/20/15     2/27/15     3/6/15     3/13/15     3/20/15     3/27/15     4/3/15    
 

 

 

   

Beginning Book Cash Balance

    $ 115,714      $ 113,161      $ 116,357      $ 116,074      $ 116,180      $ 113,183      $   110,167      $ 94,440      $ 94,841      $ 93,581      $ 92,561      $ 89,136      $ 93,150          $   115,714     

RECEIPTS

                           

Operating

    $ 5,665      $ 6,350      $ 7,120      $ 4,005      $ 3,887      $ 4,275      $ 1,892      $ 4,572      $ 4,773      $ 4,698      $ 4,560      $ 4,973      $ 5,198          $ 61,968     

Other

    4        15        15        78        99        15        15        68        89        15        15        3,155        15          3,599     
 

 

 

   

 

 

 

TOTAL RECEIPTS

    $ 5,669      $ 6,365      $ 7,135      $ 4,084      $ 3,986      $ 4,290      $ 1,907      $ 4,641      $ 4,862      $ 4,713      $ 4,575      $ 8,128      $ 5,213          $ 65,567     
 

 

 

   

 

 

 

DISBURSEMENTS

                           

U.S. Operations

                           

Payroll

    $ (3,313   $ (175   $ (3,598   $ (177   $ (3,452   $ (175   $ (13,403   $ (177   $ (3,452   $ (175   $ (3,487   $ (177   $ (3,392)         $ (35,153)    

Occupancy

    (113     (77     (264     (997     (40     (133     (292     (973     (40     (141     (292     (1,022     (40)         (4,422)    

Other Operating

    (3,854     (2,503     (3,134     (2,696     (3,491     (3,092     (2,860     (3,018     (2,630     (2,974     (3,116     (2,843     (1,912)         (38,123)    
 

 

 

   

 

 

 

Subtotal

    $ (7,279   $ (2,755   $ (6,997   $ (3,870   $ (6,983   $ (3,400   $ (16,556   $ (4,168   $ (6,121   $ (3,290   $ (6,895   $ (4,041   $ (5,344)         $ (77,698)    

E.U. Operations

    $ (647   $ (414   $ (168   $ (79   $ -      $ (158   $ (618   $ (73   $ -      $ (157   $ (618   $ (73   $ -          $ (3,004)    

Restructuring & Other

    $ (296   $ -      $ (254   $ (30   $ -      $ (3,747   $ (460   $ -      $ -      $ (2,286   $ (487   $ -      $ -          $ (7,560)    
 

 

 

   

 

 

 

TOTAL DISBURSEMENTS

    $ (8,222   $ (3,169   $ (7,418   $ (3,978   $ (6,983   $ (7,306   $ (17,634   $ (4,240   $ (6,121   $ (5,733   $ (8,000   $ (4,114   $ (5,344)         $ (88,262)    
 

 

 

   

 

 

 
 

 

 

   

 

 

 

NET CASH FLOW

    $ (2,553   $ 3,196      $ (283   $ 105      $ (2,997   $ (3,016   $ (15,726   $ 400      $ (1,260   $ (1,020   $ (3,425   $ 4,014      $ (130)         $ (22,695)    
 

 

 

   

 

 

 
 

 

 

   

 

 

 

Ending Book Cash Balance

    $   113,161      $   116,357      $   116,074      $   116,180      $   113,183      $   110,167      $ 94,440      $   94,841      $   93,581      $   92,561      $   89,136      $   93,150      $   93,019          $ 93,019